The aim of the present study was to examine the diagnostic utility of MMP-3 and MMP-7 as modern markers of early stages of BC, compared to women with benign lesions and healthy female volunteers, alone and in correlation with an accepted marker—CA 15-3. This evidence concerns the gene MMP3 and breast cancer.